Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 4,500 shares at $165.45 ($747K) on 2018-09-13, disclosed to the SEC on 2018-09-14.
Open-market sale of $747k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.45 | 2,700 | $447K | 59.8% |
| 2 | $166.63 | 1,500 | $250K | 33.5% |
| 3 | $167.49 | 300 | $50K | 6.7% |
| Total | $165.98 avg | 4,500 | $747K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $426K | — | Filing → |
| LOXO | SELL | 2018-12-12 | $120K | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |